Deena Fremont, Rhiannon Roberts, Colleen Webber, Anna E Clarke, Christina Milani, Sarina R Isenberg, Shirley H Bush, Daniel Kobewka, Luke Turcotte, Michelle Howard, Kaitlyn Boese, Amit Arya, Benoit Robert, Aynharan Sinnarajah, Jessica E Simon, Jenny Lau, Danial Qureshi, James Downar, Peter Tanuseputro
OBJECTIVE: To examine changes in the prescribing of end-of-life symptom management medications in long-term care (LTC) homes during the COVID-19 pandemic. DESIGN: Retrospective cohort study using routinely collected health administrative data in Ontario, Canada. SETTING AND PARTICIPANTS: We included all individuals who died in LTC homes between January 1, 2017, and March 31, 2021. We separated the study into 2 periods: before COVID-19 (January 1, 2017, to March 17, 2020) and during COVID-19 (March 18, 2020, to March 31, 2021)...
March 1, 2024: Journal of the American Medical Directors Association